Idiotype vaccination of myeloma patients after chemotherapy.
Massaia
M
M
Divisione di Ematologia dell'Universita di Torino, Azienda Ospedaliera San Giovanni Battista, Italy.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage; D006433:Hemocyanins / Q000008:administration & dosage; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology*; D018365:Neoplasm, Residual; D016896:Treatment Outcome; D014611:Vaccination
D000276:Adjuvants, Immunologic; D007130:Immunoglobulin Idiotypes; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin